Mupirocin is a topical antimicrobial agent that is used for the treatment of skin and postoperative wound infections, and the prevention of nasal carriage of meticillin-resistant Staphylococcus aureus (MRSA). However, the prevalence of mupirocin resistance in S. aureus, particularly in MRSA, has increased. High-level mupirocin resistance, with MICs ¢512 mg ml "1 , is mediated by the ileS-2 gene, which is located on conjugative plasmids. In the present study, we investigated whether mupirocin influences the expression of the ileS-2 gene responsible for high-level mupirocin resistance, and we present some evidence that this gene is not upregulated but constitutively expressed in S. aureus.
INTRODUCTION
Staphylococcus are among the major causes of nosocomial infections and nowadays are becoming increasingly difficult to combat because of the emerging resistance to all current antibiotic classes including vancomycin (Fluit et al., 2001) . Mupirocin, or pseudomonic acid A, is used to control the prevalence of meticillin-resistant Staphylococcus aureus (MRSA) strains. It is a natural antibiotic, produced by Pseudomonas fluorescens, that binds to the isoleucyl-tRNA synthetase (IRS) and arrests protein synthesis by preventing the incorporation of isoleucine into growing polypeptide chains (Yanagisawa et al., 1994) . The emergence of high-level mupirocin resistance in staphylococci, associated with a failure to clear the micro-organism in both colonized and infected patients, has been reported (Daskalaki et al., 2009) .
The genetics of resistance to mupirocin has been inferred from the MICs shown by the isolates. High-level mupirocin resistance (Mup R ) with MICs ¢512 mg ml 21 has been associated with high-molecular-mass plasmids (30 to 50 kb) harbouring the ileS-2 gene, which encodes a modified IRS enzyme. Thus, S. aureus high-level mupirocin-resistant strains harbour two distinct IRS enzymes: one mupirocinresistant enzyme encoded by the plasmid ileS-2 gene and the usual mupirocin-sensitive enzyme encoded by the chromosomal wild-type ileS-1 (Gilbart et al., 1993) . Alternatively, low-or intermediate-level mupirocin resistance (Mup I ), with MICs ¢4 to ¡256 mg ml 21 , shows either the presence of a mutated copy of the native ileS-1 gene on the chromosome (Gilbart et al., 1993) or a copy of the ileS-2 gene on the chromosome in addition to the native ileS-1 gene (Ramsey et al., 1996; Fujimura et al., 2001) .
Regulation of gene expression generally acts at the level of transcription by either induction or repression. Alternatively, some enzymes are not strongly controlled at all, being expressed constitutively (Watson et al., 2004) . In this report, we investigated whether the plasmid ileS-2 gene associated with high-level mupirocin resistance was constitutively expressed or induced in the presence of mupirocin in S. aureus.
METHODS
Bacterial strains. The strains used in this study were S. aureus RN8411 (Projan & Archer, 1989) , as a Mup S control, and S. aureus JJ1, a transconjugant derivative of strain RN8411 harbouring the plasmid pMG1 responsible for high-level mupirocin resistance (Mup R ) that we characterized previously . Both strains were cultivated in brain heart infusion (BHI) broth (Difco) at 37 uC.
Growth in the presence of mupirocin. Strain JJ1 was grown in BHI broth for 18 h at 37 uC. Cells were diluted in BHI broth to OD 660 0.05 and separated into two different samples. After 1 h of incubation at 37 uC, 512 mg mupirocin ml 21 were added to one of the samples. The IP: 54.70.40.11
On: Wed, 01 May 2019 17:05:36 cultures were then maintained at 37 uC and the OD 660 was determined at 1 h intervals.
Metabolic labelling of cells and gel electrophoresis. Overnight cultures were diluted in BHI broth to 10 7 c.f.u. ml 21 and incubated for 30 min at 37 uC. After centrifugation at 12 000 g for 5 min, cells were resuspended at 10 8 c.f.u. ml 21 in 100 ml samples of methioninefree minimum essential medium (Gibco) containing 200 mCi 35 Smethionine ml 21 (Amersham) (Laport et al., 2001) . All aliquots (RN8411, JJ1 or JJ1 supplied with 512 mg mupirocin ml 21 ) were maintained at 37 uC for 30 min. The labelling period was ended by placing the suspensions in an ice bath and cells were collected by centrifugation at 12 000 g for 5 min. After two washes in 0.85 % NaCl, the cells were incubated in the presence of 0.2 mg lysostaphin ml 21 (Sigma), for 2 h at 37 uC. After that, an equal volume of 0.5 M Tris/ HCl (pH 7.2) buffer containing 4 % SDS, 10 % b-mercaptoethanol, 20 % glycerol and 0.1 % bromophenol blue was added. The cell suspensions were boiled for 5 min and cellular debris was sedimented by centrifugation at 12 000 g for 5 min and discarded. Aliquots containing equal radioactive counts from each set of samples were subjected to SDS-PAGE (7.5 %). The gels were stained with Coomassie blue, destained, dried and exposed to X-ray films.
RNA isolation and hybridization. Total RNA from exponentially growing S. aureus JJ1 or RN8411 was isolated essentially using the acid-guanidine-thiocyanate-phenol/chloroform extraction method described by Chomczynski & Sacchi (1987) . To analyse the synthesis of ileS-2 mRNA, JJ1 cells were supplied with 512 mg mupirocin ml 21 and incubated for 10 min. Subsequently, the cells were disrupted by incubation with 0.2 mg lysostaphin ml 21 , in TE buffer for 2 h at 37 uC. RNA (5 mg per sample) was analysed by Northern blotting on a 1.2 % agarose-formaldehyde denaturing gel and blotted to a nitrocellulose membrane as described elsewhere (Sambrook & Russell, 2001) . The RNA blot was probed with a fragment of the S. aureus JJ1 ileS-2 gene PCR amplified according to Nunes et al. (1999) and labelled with [a-32 P]dCTP. To confirm the integrity of the RNA and the loading of equal amounts of RNA in the Northern blot gel, a replica gel was stained with ethidium bromide (0.5 mg ml 21 ).
RESULTS AND DISCUSSION
Growth of Mup R S. aureus in the presence of mupirocin
To analyse the influence of mupirocin on the rate of growth of mupirocin-resistance cells, the Mup R transconjugant JJ1 was incubated at 37 u C either in the absence or in the presence of mupirocin (512 mg ml 21 ) and growth was monitored at 1 h intervals. In the presence of mupirocin, the cultures showed slower growth (Fig. 1) . When overnight cultures were grown and kept, throughout the experiment, in the presence of mupirocin (Fig. 1) , the same slower growth was observed indicating that this delay may result from the inhibition of the sensitive mupirocin IRS, encoded by the chromosomal ileS-1 gene in the tested strain. All cultures were in the exponential growth phase after 4 h of incubation.
Expression of the ileS-2 gene
In order to analyse the expression of the ileS-2 gene at the translational level, in the presence of mupirocin, RN8344 Mup S and its derivative transconjugant JJ1 Mup R were submitted to isotopic labelling in the presence of [ 35 S]methionine. In Fig. 2(a) , we observed the presence of a high-molecular mass protein with a molecular mass (120 kDa) compatible with that of the IRS, which contains 1024 amino acids. This protein was present in the transconjugant JJ1 (lane ii) but not in the strain RN8411 (lane i). The presence of mupirocin in the JJ1 culture (lane iii) did not change the pattern of IleS-2 protein expression.
To analyse transcription of the ileS-2 gene, an equal amount of total RNA isolated from JJ1 cells, incubated either in the absence or in the presence of 512 mg mupirocin ml 21 for 10 min was analysed by Northern blotting using an ileS-2 specific probe. Three different transcripts of approximately 9.5, 5.3 and 3.4 kb were detected (Fig. 2b) . The 9.5 kb mRNA may correspond to a polycistronic transcript containing three copies of the ileS-2 gene, which seems to be arranged in tandem on the Mup R plasmids (Morton et al., 1995) . The mRNAs of 5.3 and 3.4 kb may correspond to either degradation or single monocistronic transcripts since the ileS-2 gene is 3075 bp in size (GenBank accession number X75439.1). No significant difference was detected in the amount of ileS-2 transcripts in the mupirocin-treated cells compared to the untreated ones, reinforcing the idea of constitutive expression of the ileS-2 gene.
We have previously shown that high-level mupirocin resistance was correlated with the presence of a 35 kb relaxable plasmid in a MRSA strain isolated in the hospital of Universidade Federal do Rio de Janeiro, Brazil . This plasmid, named pMG1, was transferred to strain RN8411 during overnight filter-matings and one of the transconjugants was named JJ1. In this work, the transconjugant JJ1 Mup R was shown to constitutively Fig. 1 . Influence of mupirocin on the growth of the Mup R S. aureus JJ1 strain. Cells were incubated at 37 6C without mupirocin (&) or with the addition of 512 mg mupirocin ml "1 after 1 h (indicated by an arrow) (m). As a control, another culture was pre-incubated in the presence of 512 mg mupirocin ml "1 and always kept in the presence of the drug (.). At 1 h intervals, the OD 660 was determined for each condition.
Expression of the ileS-2 gene in S. aureus express the ileS-2 gene responsible for mupirocin resistance. When the growth of Mup R JJ1 strain was analysed, the presence of mupirocin seemed to slow down the growth of the resistant strain when compared with the growth of this strain in the absence of the drug. As stated above, this may be due to the inhibition of the mupirocinsensitive IRS encoded by the chromosomal ileS-1 gene (Gilbart et al., 1993) since the same delay was observed when cells were pre-incubated and maintained throughout the experiment in the presence of mupirocin. Additionally, in the presence of mupirocin, neither transcription nor translation of the ileS-2 gene was changed resulting in no alteration in expression of mRNA and protein, respectively. Taken together, these results suggest that the expression of the high-level mupirocin-resistant ileS-2 gene is not upregulated in the presence of mupirocin.
To the best of our knowledge, this is the first report that reveals the constitutive expression of the ileS-2 gene, i.e. its expression is independent of the presence of the antimicrobial mupirocin. These data broaden our understanding of the genetics of high-level mupirocin resistance in S. aureus.
Relationship of protein structure of isoleucyl-tRNA synthetase with pseudomonic acid resistance of Escherichia coli. A proposed mode of action of pseudomonic acid as an inhibitor of isoleucyl-tRNA synthetase. J Biol Chem 269, 24304-24309. aureus JJ1 incubated for 10 min at 37 6C without ("), or with (+) 512 mg mupirocin ml "1 , separated on a 1.2 % gel, transferred to a nylon membrane and hybridized to an ileS-2-specific probe.
